The role of 'no-touch' automated room disinfection systems in infection prevention and control

Journal of Hospital Infection

Volumn 83, Issue 1, 2013, Pages 1-13

  Otter, J A ^a,b   Yezli, S ^b   Perl, T M ^c,d   Barbut, F ^e   French, G L ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b Bioquell UK Ltd   (United Kingdom)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS HOSPITAL   (United States)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

'No touch' automated room disinfection (NTD); AHP; Disinfection; H2O2; Healthcare associated infections; Hospital; HPV; Hydrogen peroxide vapour aerosol; Surface contamination; Ultraviolet radiation; UVC

Indexed keywords

CHLORINE DIOXIDE; HYDROGEN PEROXIDE; OZONE; XENON;

ACINETOBACTER BAUMANNII; AEROSOL; ANTIVIRAL ACTIVITY; BACTERICIDAL ACTIVITY; BACTERIUM CONTAMINATION; CLINICAL EFFECTIVENESS; CLOSTRIDIUM DIFFICILE; COST BENEFIT ANALYSIS; DISEASE TRANSMISSION; DISINFECTION; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; INTERMETHOD COMPARISON; NO TOUCH AUTOMATED ROOM DISINFECTION; NONHUMAN; NOROVIRUS; PULSED XENON ULTRAVIOLET SYSTEM; REVIEW; RISK REDUCTION; ROOM TEMPERATURE; ULTRAVIOLET C RADIATION; ULTRAVIOLET RADIATION; VAPOR; VIRAL CONTAMINATION;

CROSS INFECTION; DISINFECTANTS; DISINFECTION; HOSPITALS; HUMANS; INFECTION CONTROL; PATIENTS' ROOMS; ULTRAVIOLET RAYS;

EID: 84871003763     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2012.10.002     Document Type: Review

References (142)

1. Otter J.A., Yezli S., French G.L. The role played by contaminated surfaces in the transmission of nosocomial pathogens. Infect Control Hosp Epidemiol 2011, 32:687-699.
2. Maki D.G., Alvarado C.J., Hassemer C.A., Zilz M.A. Relation of the inanimate hospital environment to endemic nosocomial infection. N Engl J Med 1982, 307:1562-1566.
3. Weber D.J., Rutala W.A., Miller M.B., Huslage K., Sickbert-Bennett E. Role of hospital surfaces in the transmission of emerging health care-associated pathogens: norovirus, Clostridium difficile, and Acinetobacter species. Am J Infect Control 2010, 38:S25-S33.
4. Shaughnessy M.K., Micielli R.L., DePestel D.D., et al. Evaluation of hospital room assignment and acquisition of Clostridium difficile infection. Infect Control Hosp Epidemiol 2011, 32:201-206.
5. Datta R., Platt R., Yokoe D.S., Huang S.S. Environmental cleaning intervention and risk of acquiring multidrug-resistant organisms from prior room occupants. Arch Intern Med 2011, 171:491-494.
6. Huang S.S., Datta R., Platt R. Risk of acquiring antibiotic-resistant bacteria from prior room occupants. Arch Intern Med 2006, 166:1945-1951.
7. Drees M., Snydman D., Schmid C., et al. Prior environmental contamination increases the risk of acquisition of vancomycin-resistant enterococci. Clin Infect Dis 2008, 46:678-685.
8. Nseir S., Blazejewski C., Lubret R., Wallet F., Courcol R., Durocher A. Risk of acquiring multidrug-resistant Gram-negative bacilli from prior room occupants in the ICU. Clin Microbiol Infect 2011, 17:1201-1208.
9. Peleg A.Y., Hooper D.C. Hospital-acquired infections due to gram-negative bacteria. N Engl J Med 2010, 362:1804-1813.
10. Dubberke E.R., Reske K.A., Noble-Wang J., et al. Prevalence of Clostridium difficile environmental contamination and strain variability in multiple health care facilities. Am J Infect Control 2007, 35:315-318.
11. Rutala W.A., Weber D.J. Are room decontamination units needed to prevent transmission of environmental pathogens?. Infect Control Hosp Epidemiol 2011, 32:743-747.
12. Davies A., Pottage T., Bennett A., Walker J. Gaseous and air decontamination technologies for Clostridium difficile in the healthcare environment. J Hosp Infect 2011, 77:199-203.
13. Falagas M.E., Thomaidis P.C., Kotsantis I.K., Sgouros K., Samonis G., Karageorgopoulos D.E. Airborne hydrogen peroxide for disinfection of the hospital environment and infection control: a systematic review. J Hosp Infect 2011, 78:171-177.
14. Byrns G., Fuller T.P. The risks and benefits of chemical fumigation in the health care environment. J Occup Environ Hyg 2011, 8:104-112.
15. Weinstein R.A. Nosocomial infection update. Emerg Infect Dis 1998, 4:416-420.
16. Riddle M.M. The disinfection of sick-rooms and their contents. Am J Nursing 1901, 1:568-573.
17. Friedman H., Volin E., Laumann D. Terminal disinfection in hospitals with quaternary ammonium compounds by use of a spray-fog technique. Appl Microbiol 1968, 16:223-227.
18. Ostrander W.E., Griffith L.J. Evaluation of disinfectants for hospital housekeeping use. Appl Microbiol 1964, 12:460-463.
19. Munster A.M., Ostrander W.E. Terminal disinfection of contaminated patient care areas: to fog or not to fog?. Am Surg 1974, 40:713-715.
20. Rutala WA, Weber DJ, Healthcare Infection Control Practices Advisory Committee (HICPAC). Guideline for disinfection and sterilization in healthcare facilities. 2008.
21. Hayden M.K., Blom D.W., Lyle E.A., Moore C.G., Weinstein R.A. Risk of hand or glove contamination after contact with patients colonized with vancomycin-resistant Enterococcus or the colonized patients' environment. Infect Control Hosp Epidemiol 2008, 29:149-154.
22. Stiefel U., Cadnum J.L., Eckstein B.C., Guerrero D.M., Tima M.A., Donskey C.J. Contamination of hands with methicillin-resistant Staphylococcus aureus after contact with environmental surfaces and after contact with the skin of colonized patients. Infect Control Hosp Epidemiol 2011, 32:185-187.
23. Kramer A., Schwebke I., Kampf G. How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis 2006, 6:130.
24. Lawley T.D., Clare S., Deakin L.J., et al. Use of purified Clostridium difficile spores to facilitate evaluation of health care disinfection regimens. Appl Environ Microbiol 2010, 76:6895-6900.
25. Larson H.E., Borriello S.P. Quantitative study of antibiotic-induced susceptibility to Clostridium difficile enterocecitis in hamsters. Antimicrob Agents Chemother 1990, 34:1348-1353.
26. Yezli S., Otter J.A. Minimum infective dose of the major human respiratory and enteric viruses transmitted through food and the environment. Food Environ Microbiol 2011, 3:1-30.
27. Morter S., Bennet G., Fish J., et al. Norovirus in the hospital setting: virus introduction and spread within the hospital environment. J Hosp Infect 2011, 77:106-112.
28. Dancer S.J. How do we assess hospital cleaning? A proposal for microbiological standards for surface hygiene in hospitals. J Hosp Infect 2004, 56:10-15.
29. Walder M., Holmdahl T. Reply to Roberts. Infect Control Hosp Epidemiol 2012, 33:312-313.
30. Roberts C.G. Hydrogen peroxide vapor and aerosol room decontamination systems. Infect Control Hosp Epidemiol 2012, 33:312.
31. French G.L., Otter J.A., Shannon K.P., Adams N.M., Watling D., Parks M.J. Tackling contamination of the hospital environment by methicillin-resistant Staphylococcus aureus (MRSA): a comparison between conventional terminal cleaning and hydrogen peroxide vapour decontamination. J Hosp Infect 2004, 57:31-37.
32. Byers K.E., Durbin L.J., Simonton B.M., Anglim A.M., Adal K.A., Farr B.M. Disinfection of hospital rooms contaminated with vancomycin-resistant Enterococcus faecium. Infect Control Hosp Epidemiol 1998, 19:261-264.
33. Manian F.A., Griesenauer S., Senkel D., et al. Isolation of Acinetobacter baumannii complex and methicillin-resistant Staphylococcus aureus from hospital rooms following terminal cleaning and disinfection: can we do better?. Infect Control Hosp Epidemiol 2011, 32:667-672.
34. Wilcox M.H., Fawley W.N., Wigglesworth N., Parnell P., Verity P., Freeman J. Comparison of the effect of detergent versus hypochlorite cleaning on environmental contamination and incidence of Clostridium difficile infection. J Hosp Infect 2003, 54:109-114.
35. Carling P.C., Parry M.M., Rupp M.E., Po J.L., Dick B., Von Beheren S. Improving cleaning of the environment surrounding patients in 36 acute care hospitals. Infect Control Hosp Epidemiol 2008, 29:1035-1041.
36. Mulvey D., Redding P., Robertson C., et al. Finding a benchmark for monitoring hospital cleanliness. J Hosp Infect 2011, 77:25-30.
37. Boyce J.M., Havill N.L., Dumigan D.G., Golebiewski M., Balogun O., Rizvani R. Monitoring the effectiveness of hospital cleaning practices by use of an adenosine triphosphate bioluminescence assay. Infect Control Hosp Epidemiol 2009, 30:678-684.
38. Carling P.C., Briggs J.L., Perkins J., Highlander D. Improved cleaning of patient rooms using a new targeting method. Clin Infect Dis 2006, 42:385-388.
39. Goodman E.R., Platt R., Bass R., Onderdonk A.B., Yokoe D.S., Huang S.S. Impact of an environmental cleaning intervention on the presence of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci on surfaces in intensive care unit rooms. Infect Control Hosp Epidemiol 2008, 29:593-599.
40. Eckstein B.C., Adams D.A., Eckstein E.C., et al. Reduction of Clostridium difficile and vancomycin-resistant Enterococcus contamination of environmental surfaces after an intervention to improve cleaning methods. BMC Infect Dis 2007, 7:61.
41. Dancer S.J., White L.F., Lamb J., Girvan E.K., Robertson C. Measuring the effect of enhanced cleaning in a UK hospital: a prospective cross-over study. BMC Med 2009, 7:28.
42. Hayden M.K., Bonten M.J., Blom D.W., Lyle E.A., van de Vijver D.A., Weinstein R.A. Reduction in acquisition of vancomycin-resistant enterococcus after enforcement of routine environmental cleaning measures. Clin Infect Dis 2006, 42:1552-1560.
43. Jeanes A., Rao G., Osman M., Merrick P. Eradication of persistent environmental MRSA. J Hosp Infect 2005, 61:85-86.
44. Dettenkofer M., Block C. Hospital disinfection: efficacy and safety issues. Curr Opin Infect Dis 2005, 18:320-325.
45. McGowan M.J., Shimoda L.M., Woolsey G.D. Effects of sodium hypochlorite on denture base metals during immersion for short-term sterilization. J Prosthet Dent 1988, 60:212-218.
46. Mirabelli M.C., Zock J.P., Plana E., et al. Occupational risk factors for asthma among nurses and related healthcare professionals in an international study. Occup Environ Med 2007, 64:474-479.
47. Boyce J.M., Havill N.L., Otter J.A., et al. Impact of hydrogen peroxide vapor room decontamination on Clostridium difficile environmental contamination and transmission in a healthcare setting. Infect Control Hosp Epidemiol 2008, 29:723-729.
48. Cooper T., O'Leary M., Yezli S., Otter J.A. Impact of environmental decontamination using hydrogen peroxide vapour on the incidence of Clostridium difficile infection in one hospital Trust. J Hosp Infect 2011, 78:238-240.
49. Dryden M., Parnaby R., Dailly S., et al. Hydrogen peroxide vapour decontamination in the control of a polyclonal meticillin-resistant Staphylococcus aureus outbreak on a surgical ward. J Hosp Infect 2008, 68:190-192.
50. Kaiser M, Elemendorf S, Kent D, Evans A, Harrington SM, McKenna D. Management of a multi-year MDR Acinetobacter baumannii outbreak in the ICU setting. Infectious Diseases Society of America (IDSA) Annual Meeting. Abstract 394. 2011.
51. Otter J.A., Yezli S., Schouten M.A., van Zanten A.R., Houmes-Zielman G., Nohlmans-Paulssen M.K. Hydrogen peroxide vapor decontamination of an intensive care unit to remove environmental reservoirs of multidrug-resistant gram-negative rods during an outbreak. Am J Infect Control 2010, 38:754-756.
52. Ray A., Perez F., Beltramini A.M., et al. Use of vaporized hydrogen peroxide decontamination during an outbreak of multidrug-resistant Acinetobacter baumannii infection at a long-term acute care hospital. Infect Control Hosp Epidemiol 2010, 31:1236-1241.
53. Bates C.J., Pearse R. Use of hydrogen peroxide vapour for environmental control during a Serratia outbreak in a neonatal intensive care unit. J Hosp Infect 2005, 61:364-366.
54. Hardy K.J., Gossain S., Henderson N., et al. Rapid recontamination with MRSA of the environment of an intensive care unit after decontamination with hydrogen peroxide vapour. J Hosp Infect 2007, 66:360-368.
55. Otter J.A., Cummins M., Ahmad F., van Tonder C., Drabu Y.J. Assessing the biological efficacy and rate of recontamination following hydrogen peroxide vapour decontamination. J Hosp Infect 2007, 67:182-188.
56. Riggs M.M., Sethi A.K., Zabarsky T.F., Eckstein E.C., Jump R.L., Donskey C.J. Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clin Infect Dis 2007, 45:992-998.
57. Vonberg R.P., Gastmeier P. Nosocomial aspergillosis in outbreak settings. J Hosp Infect 2006, 63:246-254.
58. Otter J.A., Barnicoat M., Down J., Smyth D., Yezli S., Jeanes A. Hydrogen peroxide vapour decontamination of a critical care unit room used to treat a patient with Lassa fever. J Hosp Infect 2010, 75:335-337.
59. van't Veen A., van der Zee A., Nelson J., Speelberg B., Kluytmans J.A., Buiting A.G. Outbreak of infection with a multiresistant Klebsiella pneumoniae strain associated with contaminated roll boards in operating rooms. J Clin Microbiol 2005, 43:4961-4967.
60. Boyce J.M., Potter-Bynoe G., Chenevert C., King T. Environmental contamination due to methicillin-resistant Staphylococcus aureus: possible infection control implications. Infect Control Hosp Epidemiol 1997, 18:622-627.
61. Dumford D.M., Nerandzic M.M., Eckstein B.C., Donskey C.J. What is on that keyboard? Detecting hidden environmental reservoirs of Clostridium difficile during an outbreak associated with North American pulsed-field gel electrophoresis type 1 strains. Am J Infect Control 2009, 37:15-19.
62. Boyce J.M. New approaches to decontamination of rooms after patients are discharged. Infect Control Hosp Epidemiol 2009, 30:515-517.
63. Orlando P., Cristina M.L., Dallera M., Ottria G., Vitale A., Badolati G. Surface disinfection: evaluation of the efficacy of a nebulization system spraying hydrogen peroxide. J Prev Med Hyg 2008, 49:116-119.
64. Stibich M., Stachowiak J., Tanner B., et al. Evaluation of a pulsed-xenon ultraviolet room disinfection device for impact on hospital operations and microbial reduction. Infect Control Hosp Epidemiol 2011, 32:286-288.
65. Otter J.A., Havill N.L., Boyce J.M. Hydrogen peroxide vapor is not the same as aerosolized hydrogen peroxide. Infect Control Hosp Epidemiol 2010, 31:1201-1202.
66. Otter J.A., Yezli S. A call for clarity when discussing hydrogen peroxide vapour and aerosol systems. J Hosp Infect 2011, 77:83-84.
67. Shapey S., Machin K., Levi K., Boswell T.C. Activity of a dry mist hydrogen peroxide system against environmental Clostridium difficile contamination in elderly care wards. J Hosp Infect 2008, 70:136-141.
68. Chan H.T., White P., Sheorey H., Cocks J., Waters M.J. Evaluation of the biological efficacy of hydrogen peroxide vapour decontamination in wards of an Australian hospital. J Hosp Infect 2011, 79:125-128.
69. Holmdahl T., Lanbeck P., Wullt M., Walder M.H. A head-to-head comparison of hydrogen peroxide vapor and aerosol room decontamination systems. Infect Control Hosp Epidemiol 2011, 32:831-836.
70. Fu T.Y., Gent P., Kumar V. Efficacy, efficiency and safety aspects of hydrogen peroxide vapour and aerosolized hydrogen peroxide room disinfection systems. J Hosp Infect 2012, 80:199-205.
71. Andersen B.M., Rasch M., Hochlin K., Jensen F.H., Wismar P., Fredriksen J.E. Decontamination of rooms, medical equipment and ambulances using an aerosol of hydrogen peroxide disinfectant. J Hosp Infect 2006, 62:149-155.
72. Bartels M.D., Kristoffersen K., Slotsbjerg T., Rohde S.M., Lundgren B., Westh H. Environmental meticillin-resistant Staphylococcus aureus (MRSA) disinfection using dry-mist-generated hydrogen peroxide. J Hosp Infect 2008, 70:35-41.
73. Barbut F., Menuet D., Verachten M., Girou E. Comparison of the efficacy of a hydrogen peroxide dry-mist disinfection system and sodium hypochlorite solution for eradication of Clostridium difficile spores. Infect Control Hosp Epidemiol 2009, 30:515-517.
74. Piskin N., Celebi G., Kulah C., Mengeloglu Z., Yumusak M. Activity of a dry mist-generated hydrogen peroxide disinfection system against methicillin-resistant Staphylococcus aureus and Acinetobacter baumannii. Am J Infect Control 2011, 39:757-762.
75. Beswick A.J., Farrant J., Makison C., et al. Comparison of multiple systems for laboratory whole room fumigation. Applied Biosafety 2011, 16:139-157.
76. Andersen B.M., Syversen G., Thoresen H., et al. Failure of dry mist of hydrogen peroxide 5% to kill Mycobacterium tuberculosis. J Hosp Infect 2010, 76:80-83.
77. Andersen B.M. Does 'airborne' hydrogen peroxide kill Mycobacterium tuberculosis?. J Hosp Infect 2010, 77:81-83.
78. Grare M., Dailloux M., Simon L., Dimajo P., Laurain C. Efficacy of dry mist of hydrogen peroxide (DMHP) against Mycobacterium tuberculosis and use of DMHP for routine decontamination of biosafety level 3 laboratories. J Clin Microbiol 2008, 46:2955-2958.
79. Pottage T., Macken S., Walker J.T., Bennett A.M. Meticillin-resistant Staphylococcus aureus is more resistant to vaporized hydrogen peroxide than commercial Geobacillus stearothermophilus biological indicators. J Hosp Infect 2012, 80:41-45.
80. Otter J.A., French G.L. Survival of nosocomial bacteria and spores on surfaces and inactivation by hydrogen peroxide vapor. J Clin Microbiol 2009, 47:205-207.
81. McDonnell G., Russell A.D. Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev 1999, 12:147-179.
82. Meyer B., Cookson B. Does microbial resistance or adaptation to biocides create a hazard in infection prevention and control?. J Hosp Infect 2010, 76:200-205.
83. Chopra I. The increasing use of silver-based products as antimicrobial agents: a useful development or a cause for concern?. J Antimicrob Chemother 2007, 59:587-590.
84. Hall L., Otter J.A., Chewins J., Wengenack N.L. Use of hydrogen peroxide vapor for deactivation of Mycobacterium tuberculosis in a biological safety cabinet and a room. J Clin Microbiol 2007, 45:810-815.
85. Humphreys P.N. Testing standards for sporicides. J Hosp Infect 2011, 77:193-198.
86. Otter JA, Davies B, Klein J, Watts TL, Kearns AM, French GL. Identification and control of an outbreak of gentamicin-resistant, methicillin-susceptible Staphylococcus aureus on a neonatal unit. 13th International Symposium on Staphylococci and Staphylococcal Infection (ISSSI), Cairns, Australia, 2008.
87. Berrie E., Andrews L., Yezli S., Otter J.A. Hydrogen peroxide vapour (HPV) inactivation of adenovirus. Lett Appl Microbiol 2011, 52:555-558.
88. Goyal SM, Chander Y, Yezli S, Otter JA. Hydrogen peroxide vapor (HPV) inactivation of feline calicivirus, a surrogate for norovirus - an update. Infection Prevention Society Annual Meeting. 2011.
89. Pottage T., Richardson C., Parks S., Walker J.T., Bennett A.M. Evaluation of hydrogen peroxide gaseous disinfection systems to decontaminate viruses. J Hosp Infect 2010, 74:55-61.
90. Barbut F., Yezli S., Otter J.A. Activity in vitro of hydrogen peroxide vapour against Clostridium difficile spores. J Hosp Infect 2012, 80:85-87.
91. Bentley K., Dove B.K., Parks S.R., Walker J.T., Bennett A.M. Hydrogen peroxide vapour decontamination of surfaces artificially contaminated with norovirus surrogate feline calicivirus. J Hosp Infect 2012, 80:116-121.
92. Otter J.A., Yezli S., French G.L. Impact of the suspending medium on susceptibility of meticillin-resistant Staphylococcus aureus to hydrogen peroxide vapour decontamination. J Hosp Infect 2012 Sep 24, [Epub ahead of print]. http://dx.doi.org/10.1016/j.jhin.2012.08.006.
93. Chmielarczyk A., Higgins P.G., Wojkowska-Mach J., et al. Control of an outbreak of Acinetobacter baumannii infections using vaporized hydrogen peroxide. J Hosp Infect 2012, 81:239-245.
94. Manian FA, Griesenauer S, Senkel D. Impact of an intensive terminal cleaning and disinfection (C/D) protocol involving selected hospital rooms on endemic nosocomial infection (NI) rates of common pathogens at a tertiary care medical center. 5th Decennial Meeting of the Society for Healthcare Epidemiology of America (SHEA), Atlanta, GA, USA. Abstract LB6. 2010.
95. Passaretti C.L., Otter J.A., Reich N.G., et al. An evaluation of environmental decontamination with hydrogen peroxide vapor for reducing the risk of patient acquisition of multidrug-resistant organisms. Clin Infect Dis 2012 Oct 5, [Epub ahead of print].
96. Department of Health, NHS Purchasing and Supply Agency (UK). HCAI Technology Innovation Programme. Showcase Hospitals Report Number 3. The Bioquell Hydrogen Peroxide Vapour (HPV) Disinfection System. 2009.
97. Otter J.A., Yezli S. Cycle times for hydrogen peroxide vapour decontamination. Can J Microbiol 2010, 56:356-357.
98. Environmental Protection Agency (USA). Compatibility of material and electronic equipment with hydrogen peroxide and chlorine dioxide fumigation. Assessment and evaluation report. 2010.
99. Boyce J.M., Havill N.L., Moore B.A. Terminal decontamination of patient rooms using an automated mobile UV light unit. Infect Control Hosp Epidemiol 2011, 32:737-742.
100. Nerandzic M.M., Cadnum J.L., Pultz M.J., Donskey C.J. Evaluation of an automated ultraviolet radiation device for decontamination of Clostridium difficile and other healthcare-associated pathogens in hospital rooms. BMC Infect Dis 2010, 10:197.
101. Rutala W.A., Gergen M.F., Weber D.J. Room decontamination with UV radiation. Infect Control Hosp Epidemiol 2010, 31:1025-1029.
102. Pettis A.M. Elimination of Clostridium difficile infections (CDI) by illumination? Surface disinfection by ultraviolet light treatment. Am J Infect Control 2010, 38:e16-e17.
103. Reeda N.G. The history of ultraviolet germicidal irradiation for air disinfection. Public Health Rep 2010, 125:15-27.
104. Memarzadeh F., Olmsted R.N., Bartley J.M. Applications of ultraviolet germicidal irradiation disinfection in healthcare facilities: effective adjunct, but not stand-alone technology. Am J Infect Control 2010, 38:S13-S24.
105. Enhanced environmental disinfection systems. Health Devices 2011, 40:150-162. ECRI (Emergency Care Research Institute).
106. Harrington B.J., Valigosky M. Monitoring ultraviolet lamps in biological safety cabinets with cultures of standard bacterial strains on TSA blood agar. Labmedicine 2007, 38:165-168.
107. Tyan Y.C., Liao J.D., Klauser R., IeD Wu, Weng C.C. Assessment and characterization of degradation effect for the varied degrees of ultra-violet radiation onto the collagen-bonded polypropylene non-woven fabric surfaces. Biomaterials 2002, 23:65-76.
108. Anderson P. Mutagenesis. Methods Cell Biol 1995, 48:31-58.
109. Levin J, Parrish C, Riley L, English D. The use of portable pulsed xenon ultraviolet light (PPX-UV) after terminal cleaning was associated with a dramatic decrease in the hospital-associated Clostridium difficile infection (HA-CDI) rate in a community hospital. Infectious Diseases Society of America (IDSA) Annual Meeting. Abstract 342. 2011.
110. Sharma M., Hudson J.B. Ozone gas is an effective and practical antibacterial agent. Am J Infect Control 2008, 36:559-563.
111. Moat J., Cargill J., Shone J., Upton M. Application of a novel decontamination process using gaseous ozone. Can J Microbiol 2009, 55:928-933.
112. Li C.S., Wang Y.C. Surface germicidal effects of ozone for microorganisms. AIHA J (Fairfax, Va) 2003, 64:533-537.
113. Occupational Safety and Health Administration (OSHA). Occupational safety and health guideline for hydrogen peroxide. Washington, DC: US Department of Labor; not dated.
114. Executive and Safety Executive. EH40/2005 Workplace exposure limits. Bootle, UK: HSE; 2005.
115. Galvin S., Boyle M., Russell R.J., et al. Evaluation of vaporized hydrogen peroxide, Citrox and pH neutral Ecasol for decontamination of an enclosed area: a pilot study. J Hosp Infect 2012, 80:67-70.
116. Clark J., Barrett S.P., Rogers M., Stapleton R. Efficacy of super-oxidized water fogging in environmental decontamination. J Hosp Infect 2006, 64:386-390.
117. Tuladhar E., Terpstra P., Koopmans M., Duizer E. Virucidal efficacy of hydrogen peroxide vapour disinfection. J Hosp Infect 2012, 80:110-115.
118. Taneja N., Biswal M., Kumar A., et al. Hydrogen peroxide vapour for decontaminating air-conditioning ducts and rooms of an emergency complex in northern India: time to move on. J Hosp Infect 2011, 78:200-203.
119. De Lorenzi S., Romanini L., Finzi G., Barrai I., Salvatorelli G. Reducing microbial contamination of surfaces using RelyOn Virkosept aerosol spray. J Hosp Infect 2011, 78:240-241.
120. Callahan K.L., Beck N.K., Duffield E.A., Shin G., Meschke J.S. Inactivation of methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecium (VRE) on various environmental surfaces by mist application of a stabilized chlorine dioxide and quaternary ammonium compound-based disinfectant. J Occup Environ Hyg 2010, 7:529-534.
121. Sweeney C.P., Dancer S.J. Can hospital computers be disinfected using a hand-held UV light source?. J Hosp Infect 2009, 72:92-94.
122. Kac G., Podglajen I., Si-Mohamed A., Rodi A., Grataloup C., Meyer G. Evaluation of ultraviolet C for disinfection of endocavitary ultrasound transducers persistently contaminated despite probe covers. Infect Control Hosp Epidemiol 2010, 31:165-170.
123. Otter J.A., Puchowicz M., Ryan D., et al. Feasibility of routinely using hydrogen peroxide vapor to decontaminate rooms in a busy United States hospital. Infect Control Hosp Epidemiol 2009, 30:574-577.
124. Havill N.L., Moore B.A., Boyce J.M. Comparison of the microbiological efficacy of hydrogen peroxide vapor and ultraviolet light processes for room decontamination. Infect Control Hosp Epidemiol 2012, 33:507-512.
125. Otter J.A., Yezli S. Are commercially available Geobacillus stearothermophilus biological indicators an appropriate standard for hydrogen peroxide vapour systems in hospitals?. J Hosp Infect 2012, 80:272-273.
126. Vickery K., Deva A., Jacombs A., Allan J., Valente P., Gosbell I.B. Presence of biofilm containing viable multiresistant organisms despite terminal cleaning on clinical surfaces in an intensive care unit. J Hosp Infect 2012, 80:52-55.
127. Smith K., Hunter I.S. Efficacy of common hospital biocides with biofilms of multi-drug resistant clinical isolates. J Med Microbiol 2008, 57:966-973.
128. Environmental Protection Agency (USA). Standard operating procedure for AOAC use dilution method for testing disinfectants. Fort Meade, MD: EPA; 2010.
129. Society for Healthcare Epidemiology of America (SHEA), Association for Professionals in Infection Control and Epidemiology (APIC), Association for the Healthcare Environment (AHE). SHEA, APIC and AHE respond to EPA regarding fogging applications. Arlington, VA: SHEA; 2011.
130. Environmental Protection Agency (USA). EPA issues order to NJ hospital group. Washington, DC: EPA; 2011.
131. Agence Française de Sécurité Sanitaire des Produits de Santé (AFSSAPS). Appareils de désinfection des surfaces par voie aerienne. Paris: AFSSAPS; 2011.
132. Low A. Regulation of sporicides under the European Biocidal Products Directive. J Hosp Infect 2011, 77:189-192.
133. Department of Health, Health Protection Agency (UK). Clostridium difficile: how to deal with the problem. London: HPA; 2009.
134. Fraise A. Currently available sporicides for use in healthcare, and their limitations. J Hosp Infect 2011, 77:210-212.
135. Havill N.L., Havill H.L., Mangione E., Dumigan D.G., Boyce J.M. Cleanliness of portable medical equipment disinfected by nursing staff. Am J Infect Control 2011, 39:602-604.
136. Dancer S.J. Mopping up hospital infection. J Hosp Infect 1999, 43:85-100.
137. Weber D.J., Rutala W.A., Sickbert-Bennett E.E. Outbreaks associated with contaminated antiseptics and disinfectants. Antimicrob Agents Chemother 2007, 51:4217-4224.
138. Werry C., Lawrence J.M., Sanderson P.J. Contamination of detergent cleaning solutions during hospital cleaning. J Hosp Infect 1988, 11:44-49.
139. Mahamat A., MacKenzie F.M., Brooker K., Monnet D.L., Daures J.P., Gould I.M. Impact of infection control interventions and antibiotic use on hospital MRSA: a multivariate interrupted time-series analysis. Int J Antimicrob Agents 2007, 30:169-176.
140. Verity P., Wilcox M.H., Fawley W., Parnell P. Prospective evaluation of environmental contamination by Clostridium difficile in isolation side rooms. J Hosp Infect 2001, 49:204-209.
141. Mayfield J.L., Leet T., Miller J., Mundy L.M. Environmental control to reduce transmission of Clostridium difficile. Clin Infect Dis 2000, 31:995-1000.
142. Kahnert A., Seiler P., Stein M., Aze B., McDonnell G., Kaufmann S.H. Decontamination with vaporized hydrogen peroxide is effective against Mycobacterium tuberculosis. Lett Appl Microbiol 2005, 40:448-452.